Hedge Fund - Cormorant Asset Management
Reata Pharmaceuticals Inc (RETA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2021 - Q4 (2021-12-31) | $0 | 0% | 0 | $77.02 |
| 2 | 2021 - Q3 (2021-09-30) | $10,061,000 | 0.4% | 100,000 | $117.22 |
| 3 | 2021 - Q2 (2021-06-30) | $23,798,000 | 0.8% | 168,150 | $112.92 |
| 4 | 2021 - Q1 (2021-03-31) | $39,880,000 | 0.88% | 400,000 | $116.64 |
| 5 | 2020 - Q4 (2020-12-31) | $61,810,000 | 1.47% | 500,000 | $131.41 |
| 6 | 2020 - Q3 (2020-09-30) | $43,839,000 | 1.68% | 450,000 | $124.95 |
| 7 | 2020 - Q2 (2020-06-30) | $62,408,000 | 2.38% | 400,000 | $152.02 |
| 8 | 2020 - Q1 (2020-03-31) | $70,323,000 | 3.26% | 487,206 | $193.06 |
| 9 | 2019 - Q4 (2019-12-31) | $166,897,000 | 6.65% | 816,400 | $182.43 |
| 10 | 2019 - Q3 (2019-09-30) | $65,819,000 | 4% | 819,769 | $84.86 |
| 11 | 2019 - Q2 (2019-06-30) | $76,060,000 | 4.36% | 806,150 | $86.34 |
| 12 | 2019 - Q1 (2019-03-31) | $52,564,000 | 3.55% | 615,000 | $83.01 |
| 13 | 2018 - Q4 (2018-12-31) | $37,825,000 | 3.07% | 674,251 | $61.05 |
| 14 | 2018 - Q3 (2018-09-30) | $53,962,000 | 3.5% | 660,000 | $70.47 |
| 15 | 2018 - Q2 (2018-06-30) | $15,737,000 | 1.16% | 450,000 | $30.46 |
| 16 | 2018 - Q1 (2018-03-31) | $9,230,000 | 0.68% | 450,000 | $25.74 |
| 17 | 2017 - Q4 (2017-12-31) | $5,664,000 | 0.59% | 200,000 | $27.90 |
| 18 | 2017 - Q3 (2017-09-30) | $12,085,000 | 2.13% | 388,574 | $30.07 |
The displayed share prices are average quarterly stock market prices.